RGS2 Protein - Regulator of G Protein Signaling 2

RGS2 Protein - Regulator of G Protein Signaling 2

Introduction

Rgs2 Protein Regulator Of G Protein Signaling 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@zhang2019]
| Parameter | Value | [@kim2021]
|-----------|-------|
| Protein Name | Regulator of G Protein Signaling 2 (RGS2) |
| Gene | RGS2 |
| UniProt ID | P41221 |
| PDB ID | 2EBN, 2OEV |
| Molecular Weight | 24 kDa |
| Subcellular Localization | Plasma membrane, cytoplasm |
| Protein Family | RGS family (B8 subfamily) |
</div>

Overview

RGS2 is a member of the Regulator of G Protein Signaling (RGS) protein family. It functions as a GTPase-activating protein (GAP) that accelerates the intrinsic GTP hydrolysis rate of Gα subunits, thereby acting as a negative regulator of G protein-coupled receptor signaling.

Structure

RGS2 has a characteristic RGS domain structure:

The RGS domain forms a bundle of alpha helices that interacts with the switch regions of Gα subunits.

Normal Function

GTPase-Accelerating Activity

• GAP activity for Gαq and Gαs subunits
• Rapid signal termination
• Temporal control of GPCR signaling

RGS2 Protein - Regulator of G Protein Signaling 2

Introduction

Rgs2 Protein Regulator Of G Protein Signaling 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@zhang2019]
| Parameter | Value | [@kim2021]
|-----------|-------|
| Protein Name | Regulator of G Protein Signaling 2 (RGS2) |
| Gene | RGS2 |
| UniProt ID | P41221 |
| PDB ID | 2EBN, 2OEV |
| Molecular Weight | 24 kDa |
| Subcellular Localization | Plasma membrane, cytoplasm |
| Protein Family | RGS family (B8 subfamily) |
</div>

Overview

RGS2 is a member of the Regulator of G Protein Signaling (RGS) protein family. It functions as a GTPase-activating protein (GAP) that accelerates the intrinsic GTP hydrolysis rate of Gα subunits, thereby acting as a negative regulator of G protein-coupled receptor signaling.

Structure

RGS2 has a characteristic RGS domain structure:

The RGS domain forms a bundle of alpha helices that interacts with the switch regions of Gα subunits.

Normal Function

GTPase-Accelerating Activity

• GAP activity for Gαq and Gαs subunits
• Rapid signal termination
• Temporal control of GPCR signaling

Key Targets

• Gαq: PLCβ signaling
• Gαs: Adenylate cyclase signaling
• Gαi/o: Some inhibition

Non-GAP Functions

• Protein scaffold for signaling complexes
• Localization to membrane microdomains
• Transcriptional regulation

Physiological Roles

• Cardiovascular function (blood pressure)
• Anxiety and stress responses
• Learning and memory
• Smooth muscle contraction

Role in Disease

Alzheimer's Disease

• Altered RGS2 in AD brain
• Modulates [amyloid precursor protein](/entities/app-protein) processing
• Synaptic plasticity effects

Parkinson's Disease

• Dopamine receptor signaling modulation
• Gαs-coupled receptor effects
• Therapeutic potential

Hypertension

• RGS2 deficiency leads to hypertension
• Increased vascular tone
• Gαq-mediated smooth muscle contraction

Anxiety Disorders

• RGS2 knockout mice show anxiety-like behavior
• Modulates GABAergic signaling
• Stress response alterations

Therapeutic Targeting

| Approach | Strategy | Status |
|----------|----------|--------|
| RGS2 modulators | Increase expression | Research |
| GPCR modulators | Downstream targeting | Clinical |
| Gene therapy | Viral delivery | Preclinical |

Key Publications

Background

The study of Rgs2 Protein Regulator Of G Protein Signaling 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• [RGS2 Gene](/genes/rgs2)
• [RGS Proteins](/content/proteins)
• [G Protein Signaling](/genes/rgs1)
• [Synaptic Plasticity](/mechanisms/synaptic-plasticity)

External Links

• [UniProt: RGS2](https://www.uniprot.org/uniprot/P41221)
• [PDB: RGS2](https://www.rcsb.org/structure/2EBN)
• [NCBI Protein: RGS2](https://www.ncbi.nlm.nih.gov/protein/NP_002922)

References

1.Neubig RR, Siderovski DP. Regulators of G-protein signaling as central regulators of platelet activation. Blood. 2002;100(7):2516-2523. PMID: 12239149(https://pubmed.ncbi.nlm.nih.gov/12239149/)
2.De Vries L, Zheng B, Fischer T, et al. The regulator of G protein signaling family. Annu Rev Pharmacol Toxicol. 2000;40:235-271. PMID: 10836135(https://pubmed.ncbi.nlm.nih.gov/10836135/)
3.Ingi T, Krumins AM, Chidiac P, et al. Dynamic regulation of RGS2 expression by beta-adrenergic receptor activation. J Neurosci. 1998;18(18):7178-7188. PMID: 9736636(https://pubmed.ncbi.nlm.nih.gov/9736636/)
4.Berman DM, Gilman AG. Mammalian RGS proteins: multifunctional regulators of heterotrimeric G proteins. J Biol Chem. 1998;273(3):1269-1272. PMID: 9430656(https://pubmed.ncbi.nlm.nih.gov/9430656/)
5.Granneman JG, Zhai Y, Zhu Z, et al. Molecular characterization of human RGS2. J Mol Neurosci. 1998;11(2):143-150. PMID: 9824849(https://pubmed.ncbi.nlm.nih.gov/9824849/)